Literature DB >> 25710922

Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.

Gabriela Vazquez-Benitez1, Jay R Desai2, Stanley Xu3, Glenn K Goodrich3, Emily B Schroeder3, Gregory A Nichols4, Jodi Segal5, Melissa G Butler6, Andrew J Karter7, John F Steiner3, Katherine M Newton8, Leo S Morales9, Ram D Pathak10, Abraham Thomas11, Kristi Reynolds12, H Lester Kirchner13, Beth Waitzfelder14, Jennifer Elston Lafata15, Renuka Adibhatla2, Zhiyuan Xu2, Patrick J O'Connor2.   

Abstract

OBJECTIVE: The objective of this study was to assess the incidence of major cardiovascular (CV) hospitalization events and all-cause deaths among adults with diabetes with or without CV disease (CVD) associated with inadequately controlled glycated hemoglobin (A1C), high LDL cholesterol (LDL-C), high blood pressure (BP), and current smoking. RESEARCH DESIGN AND METHODS: Study subjects included 859,617 adults with diabetes enrolled for more than 6 months during 2005-2011 in a network of 11 U.S. integrated health care organizations. Inadequate risk factor control was classified as LDL-C ≥100 mg/dL, A1C ≥7% (53 mmol/mol), BP ≥140/90 mm Hg, or smoking. Major CV events were based on primary hospital discharge diagnoses for myocardial infarction (MI) and acute coronary syndrome (ACS), stroke, or heart failure (HF). Five-year incidence rates, rate ratios, and average attributable fractions were estimated using multivariable Poisson regression models.
RESULTS: Mean (SD) age at baseline was 59 (14) years; 48% of subjects were female, 45% were white, and 31% had CVD. Mean follow-up was 59 months. Event rates per 100 person-years for adults with diabetes and CVD versus those without CVD were 6.0 vs. 1.7 for MI/ACS, 5.3 vs. 1.5 for stroke, 8.4 vs. 1.2 for HF, 18.1 vs. 40 for all CV events, and 23.5 vs. 5.0 for all-cause mortality. The percentages of CV events and deaths associated with inadequate risk factor control were 11% and 3%, respectively, for those with CVD and 34% and 7%, respectively, for those without CVD.
CONCLUSIONS: Additional attention to traditional CV risk factors could yield further substantive reductions in CV events and mortality in adults with diabetes.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25710922      PMCID: PMC4876667          DOI: 10.2337/dc14-1877

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  43 in total

1.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Developing and validating a diabetes database in a large health system.

Authors:  Janice C Zgibor; Trevor J Orchard; Melissa Saul; Gretchen Piatt; Kristine Ruppert; Andrew Stewart; Linda M Siminerio
Journal:  Diabetes Res Clin Pract       Date:  2006-08-28       Impact factor: 5.602

3.  Building a virtual cancer research organization.

Authors:  Mark C Hornbrook; Gene Hart; Jennifer L Ellis; Donald J Bachman; Gary Ansell; Sarah M Greene; Edward H Wagner; Roy Pardee; Mark M Schmidt; Ann Geiger; Amy L Butani; Terry Field; Hassan Fouayzi; Irina Miroshnik; Liyan Liu; Robert Diseker; Karen Wells; Rick Krajenta; Lois Lamerato; Christine Neslund Dudas
Journal:  J Natl Cancer Inst Monogr       Date:  2005

4.  Causes of death among diabetic patients in Denmark.

Authors:  M B Hansen; M L Jensen; B Carstensen
Journal:  Diabetologia       Date:  2011-11-30       Impact factor: 10.122

5.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

6.  Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Authors:  Sophia Zoungas; John Chalmers; Bruce Neal; Laurent Billot; Qiang Li; Yoichiro Hirakawa; Hisatomi Arima; Helen Monaghan; Rohina Joshi; Stephen Colagiuri; Mark E Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Liu Lisheng; Giuseppe Mancia; Michel Marre; David R Matthews; Carl E Mogensen; Vlado Perkovic; Neil Poulter; Anthony Rodgers; Bryan Williams; Stephen MacMahon; Anushka Patel; Mark Woodward
Journal:  N Engl J Med       Date:  2014-09-19       Impact factor: 91.245

7.  Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project.

Authors:  Gregory A Nichols; Jay Desai; Jennifer Elston Lafata; Jean M Lawrence; Patrick J O'Connor; Ram D Pathak; Marsha A Raebel; Robert J Reid; Joseph V Selby; Barbara G Silverman; John F Steiner; W F Stewart; Suma Vupputuri; Beth Waitzfelder
Journal:  Prev Chronic Dis       Date:  2012-06-07       Impact factor: 2.830

8.  The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.

Authors:  Sarah Stark Casagrande; Judith E Fradkin; Sharon H Saydah; Keith F Rust; Catherine C Cowie
Journal:  Diabetes Care       Date:  2013-02-15       Impact factor: 19.112

9.  An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors.

Authors:  Simon Rückinger; Rüdiger von Kries; André Michael Toschke
Journal:  BMC Med Res Methodol       Date:  2009-01-23       Impact factor: 4.615

Review 10.  Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.

Authors:  Bishnu H Subedi; Parag H Joshi; Steven R Jones; Seth S Martin; Michael J Blaha; Erin D Michos
Journal:  Vasc Health Risk Manag       Date:  2014-04-08
View more
  35 in total

Review 1.  Vascular repair strategies in type 2 diabetes: novel insights.

Authors:  Kira Kuschnerus; Ulf Landmesser; Nicolle Kränkel
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

Review 2.  Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Authors:  An Pan; Yeli Wang; Mohammad Talaei; Frank B Hu
Journal:  Circulation       Date:  2015-08-26       Impact factor: 29.690

3.  Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes.

Authors:  Maija Feodoroff; Valma Harjutsalo; Carol Forsblom; Per-Henrik Groop
Journal:  Diabetologia       Date:  2018-09-18       Impact factor: 10.122

4.  Impact of different dietary approaches on blood lipid control in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.

Authors:  Manuela Neuenschwander; Georg Hoffmann; Lukas Schwingshackl; Sabrina Schlesinger
Journal:  Eur J Epidemiol       Date:  2019-06-14       Impact factor: 8.082

5.  Characteristics and Delivery of Diabetes Shared Medical Appointments in North Carolina.

Authors:  Connor Drake; Julienne K Kirk; John B Buse; David Edelman; Christopher M Shea; Susan Spratt; Laura A Young; Anna R Kahkoska
Journal:  N C Med J       Date:  2019 Sep-Oct

Review 6.  SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.

Authors:  Erik J M van Bommel; Marcel H A Muskiet; Lennart Tonneijck; Mark H H Kramer; Max Nieuwdorp; Daniel H van Raalte
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 8.237

7.  Role of regular physical activity in modifying cardiovascular disease risk factors among elderly Korean women.

Authors:  Seunghui Baek; Lorraine S Evangelista; Youngmee Kim
Journal:  Int J Appl Sports Sci       Date:  2018-06

8.  Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.

Authors:  Nathan D Wong; Yanglu Zhao; Rohini Patel; Christopher Patao; Shaista Malik; Alain G Bertoni; Adolfo Correa; Aaron R Folsom; Sumesh Kachroo; Jayanti Mukherjee; Herman Taylor; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-03-29       Impact factor: 19.112

9.  Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes.

Authors:  Magnus O Wijkman; Mary Dena; Sofia Dahlqvist; Sheyda Sofizadeh; Irl Hirsch; Jaakko Tuomilehto; Johan Mårtensson; Ole Torffvit; Henrik Imberg; Aso Saeed; Marcus Lind
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-05       Impact factor: 3.738

10.  Trajectory of systolic blood pressure in a low-income, racial-ethnic minority cohort with diabetes and baseline uncontrolled hypertension.

Authors:  Leah L Zullig; Yuanyuan Liang; Shruthi Vale Arismendez; Aron Trevino; Hayden B Bosworth; Barbara J Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-04-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.